UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A computational tool for quantitative analysis of vascular networks

PloS one, 2011-11, Vol.6 (11), p.e27385-e27385

2011

Volltextzugriff (PDF)

Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients

Nature communications, 2019-04, Vol.10 (1), p.1772-1772, Article 1772

2019

Volltextzugriff (PDF)

Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies

Blood cancer journal (New York), 2022-02, Vol.12 (2), p.32-32, Article 32

2022

Volltextzugriff (PDF)

Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature

Cancer cell, 2017-04, Vol.31 (4), p.501-515.e8

2017

Volltextzugriff (PDF)

Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug release

The Journal of clinical investigation, 2018-07, Vol.128 (7), p.2927-2943

2018

Volltextzugriff (PDF)

The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity

Cancer immunology research, 2019-09, Vol.7 (9), p.1457-1471

2019

Volltextzugriff (PDF)

hnRNP A2/B1 Modulates Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines

Cancer research (Chicago, Ill.), 2010-09, Vol.70 (18), p.7137-7147

2010

Volltextzugriff (PDF)

GPR124 Functions as a WNT7-Specific Coactivator of Canonical β-Catenin Signaling

Cell reports (Cambridge), 2015-01, Vol.10 (2), p.123-130

2015

Volltextzugriff (PDF)

Cancer cell survival depends on collagen uptake into tumor-associated stroma

Nature communications, 2022-11, Vol.13 (1), p.7078-7078, Article 7078

2022

Volltextzugriff (PDF)

GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood-brain barrier

Proceedings of the National Academy of Sciences - PNAS, 2011-04, Vol.108 (14), p.5759-5764

2011

Volltextzugriff (PDF)

The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers

The Journal of clinical investigation, 2008-02, Vol.118 (2), p.640-650

2008

Volltextzugriff (PDF)

First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers

Cancer chemotherapy and pharmacology, 2022-04, Vol.89 (4), p.499-514

2022

Volltextzugriff (PDF)

The central role of adrenomedullin in host defense

Journal of leukocyte biology, 2006-08, Vol.80 (2), p.237-244

2006

Volltextzugriff (PDF)

Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms

Proceedings of the National Academy of Sciences - PNAS, 2009-03, Vol.106 (10), p.3958-3963

2009

Volltextzugriff (PDF)

Aryl Hydrocarbon Receptor-Induced Adrenomedullin Mediates Cigarette Smoke Carcinogenicity in Humans and Mice

Cancer research (Chicago, Ill.), 2012-11, Vol.72 (22), p.5790-5800

2012

Volltextzugriff (PDF)

BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma

Journal for immunotherapy of cancer, 2023-05, Vol.11 (5), p.e006684

2023

Volltextzugriff (PDF)

PI3K signaling through the dual GTPase-activating protein ARAP3 is essential for developmental angiogenesis

Science signaling, 2010-10, Vol.3 (145), p.ra76

2010

Volltextzugriff (PDF)

Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition

Cancer research (Chicago, Ill.), 2005-05, Vol.65 (10), p.4181-4190

2005

Volltextzugriff (PDF)

S100: FIRST PHASE 3 RESULTS FROM CARTITUDE‐4: CILTA‐CEL VERSUS STANDARD OF CARE (PVD OR DPD) IN LENALIDOMIDE‐REFRACTORY MULTIPLE MYELOMA

HemaSphere, 2023-08, Vol.7 (S3), p.e471416f-n/a

2023

Volltextzugriff (PDF)

S202: CARTITUDE‐1 FINAL RESULTS: PHASE 1B/2 STUDY OF CILTACABTAGENE AUTOLEUCEL IN HEAVILY PRETREATED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

HemaSphere, 2023-08, Vol.7 (S3), p.e6102468-n/a

2023

Volltextzugriff (PDF)

JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted Listeria monocytogenes–Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies

JTO clinical and research reports, 2021-02, Vol.2 (2), p.100103-100103, Article 100103

2021

Volltextzugriff (PDF)

Functional Characterization of Filamin A Interacting Protein 1-Like, a Novel Candidate for Antivascular Cancer Therapy

Cancer research (Chicago, Ill.), 2008-09, Vol.68 (18), p.7332-7341

2008

Volltextzugriff (PDF)

Gastrin-releasing peptide (GRP) induces angiogenesis and the specific GRP blocker 77427 inhibits tumor growth in vitro and in vivo

Oncogene, 2005-06, Vol.24 (25), p.4106-4113

2005

Volltextzugriff (PDF)

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

The Lancet (British edition), 2021-07, Vol.398 (10297), p.314-324

2021

Volltextzugriff (PDF)

1 – 25 von 138

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(128)
Mit Volltextzugriff
(124)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A computational tool for quantitative analysis of vascular networks

Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients

Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies

Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature

Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug release

The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity

hnRNP A2/B1 Modulates Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines

GPR124 Functions as a WNT7-Specific Coactivator of Canonical β-Catenin Signaling

Cancer cell survival depends on collagen uptake into tumor-associated stroma

GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood-brain barrier

The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers

First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers

The central role of adrenomedullin in host defense

Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms

Aryl Hydrocarbon Receptor-Induced Adrenomedullin Mediates Cigarette Smoke Carcinogenicity in Humans and Mice

BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma

PI3K signaling through the dual GTPase-activating protein ARAP3 is essential for developmental angiogenesis

Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition

S100: FIRST PHASE 3 RESULTS FROM CARTITUDE‐4: CILTA‐CEL VERSUS STANDARD OF CARE (PVD OR DPD) IN LENALIDOMIDE‐REFRACTORY MULTIPLE MYELOMA

S202: CARTITUDE‐1 FINAL RESULTS: PHASE 1B/2 STUDY OF CILTACABTAGENE AUTOLEUCEL IN HEAVILY PRETREATED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted Listeria monocytogenes–Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies

Functional Characterization of Filamin A Interacting Protein 1-Like, a Novel Candidate for Antivascular Cancer Therapy

Gastrin-releasing peptide (GRP) induces angiogenesis and the specific GRP blocker 77427 inhibits tumor growth in vitro and in vivo

Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

Suchergebnisse filtern